Performance Comparison of Microfluidic and Immunomagnetic Platforms for Pancreatic CTC Enrichment
November 15, 2025
Brand Name :
Opcon-a, Visine-A, naphcon-A
Synonyms :
Naphazoline hydrochloride and pheniramine maleate
Class :
Antihistamine, decongestant
Dosage Forms & StrengthsÂ
Ophthalmic solutionÂ
0.025%/0.3%Â
0.027%/0.3%Â
Solution
Ophthalmic solution
up to 4 times a day
1-2 drops instilled into the affected eye
Dosage Forms & StrengthsÂ
Ophthalmic solutionÂ
0.025%/0.3%Â
0.027%/0.3%Â
<6 years: Not established:
>6 years: 1-2 drops instilled into the affected eye up to 4 times a day
may increase the hypertension effect of alfa one agonist
may increase the hypertension effect of sympathomimetic drugs
may decrease the therapeutic effects of decongestants
may increase the hypertension effect of sympathomimetic drugs
may increase the vasoconstriction effect of sympathomimetic drugs
may increase the vasoconstriction effect of sympathomimetic drugs
may increase the vasoconstriction effect of sympathomimetic drugs
may increase the vasoconstriction effect of sympathomimetic drugs
may increase the vasoconstriction effect of sympathomimetic drugs
may increase the adverse effect of sympathomimetic drugs
may increase the adverse effect of sympathomimetic drugs
may increase the adverse effect of sympathomimetic drugs
may increase the adverse effect of sympathomimetic drugs
may increase the adverse effect of sympathomimetic drugs
may decrease the constriction effects of alpha-1 agonist
bunazosin (Not available in the United States)
may decrease the constriction effects of alpha-1 agonist
may decrease the constriction effects of alpha-1 agonist
may decrease the constriction effects of alpha-1 agonist
may decrease the constriction effects of alpha-1 agonist
may increase the hypertension effect of sympathomimetic drugs
may increase the adverse effect of sympathomimetic drugs
may diminish the serum concentration of decongestants
may increase the tachycardiac effect of sympathomimetic drugs
may increase the hypertension effect of sympathomimetic drugs
may increase the hypertension effect of alfa one agonist
may increase the hypertension effect of sympathomimetic drugs
may increase the hypertension effect of sympathomimetic drugs
may increase the therapeutic effect of alfa one agonist
Frequency defined:Â Â
Ocular erythemaÂ
Stinging sensation upon instillationÂ
MydriasisÂ
Pregnancy consideration: Insufficient data availableÂ
Lactation: Excretion of the drug in human breast milk is unknownÂ
Pregnancy category:Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.  Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.   Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this categoryÂ
Patient information leafletÂ
Generic Name: Naphazoline/pheniramineÂ
Pronounced: na-FAZ-oh-leen/ fen-EER-a-meenÂ
Why do we use Naphazoline/pheniramine?Â
It is intended to temporarily treat allergy-related ocular symptoms like eye redness, puffiness, itching, and watering.Â